Holdings (Monthly)
Guide ↗
ALPS Medical Breakthroughs ETF
· Alps Etf Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Kymera Therapeutics Inc | 501575104 | Feb 2026 | 70,365 | $6.4M | 4.66% | EC |
| 2 | Celcuity Inc | 15102K100 | Feb 2026 | 41,241 | $4.6M | 3.34% | EC |
| 3 | Alkermes Plc | G01767105 | Feb 2026 | 147,168 | $4.4M | 3.21% | EC |
| 4 | Cg Oncology Inc | 156944100 | Feb 2026 | 71,897 | $4.2M | 3.06% | EC |
| 5 | Mirum Pharmaceuticals Inc | 604749101 | Feb 2026 | 45,804 | $4.2M | 3.06% | EC |
| 6 | Amicus Therapeutics Inc | 03152W109 | Feb 2026 | 274,988 | $4.0M | 2.86% | EC |
| 7 | Acadia Pharmaceuticals Inc | 004225108 | Feb 2026 | 150,789 | $3.7M | 2.68% | EC |
| 8 | Newamsterdam Pharma Co Nv | N62509109 | Feb 2026 | 101,063 | $3.6M | 2.60% | EC |
| 9 | Crinetics Pharmaceuticals Inc | 22663K107 | Feb 2026 | 84,576 | $3.5M | 2.52% | EC |
| 10 | Apogee Therapeutics Inc | 03770N101 | Feb 2026 | 48,872 | $3.4M | 2.48% | EC |
| 11 | Viking Therapeutics Inc | 92686J106 | Feb 2026 | 100,746 | $3.4M | 2.47% | EC |
| 12 | Structure Therapeutics Inc | 86366E106 | Feb 2026 | 54,083 | $3.4M | 2.47% | EC |
| 13 | Xenon Pharmaceuticals Inc | 98420N105 | Feb 2026 | 68,873 | $3.0M | 2.16% | EC |
| 14 | Spyre Therapeutics Inc | 00773J202 | Feb 2026 | 69,157 | $3.0M | 2.15% | EC |
| 15 | Edgewise Therapeutics Inc | 28036F105 | Feb 2026 | 94,360 | $2.9M | 2.08% | EC |
| 16 | Tarsus Pharmaceuticals Inc | 87650L103 | Feb 2026 | 37,835 | $2.9M | 2.07% | EC |
| 17 | Denali Therapeutics Inc | 24823R105 | Feb 2026 | 131,033 | $2.8M | 2.01% | EC |
| 18 | Ideaya Biosciences Inc | 45166A102 | Feb 2026 | 78,135 | $2.5M | 1.82% | EC |
| 19 | Travere Therapeutics Inc | 89422G107 | Feb 2026 | 79,744 | $2.4M | 1.72% | EC |
| 20 | Apellis Pharmaceuticals Inc | 03753U106 | Feb 2026 | 112,768 | $2.4M | 1.71% | EC |
| 21 | Vera Therapeutics Inc | 92337R101 | Feb 2026 | 56,977 | $2.3M | 1.68% | EC |
| 22 | Disc Medicine Inc | 254604101 | Feb 2026 | 33,646 | $2.2M | 1.62% | EC |
| 23 | Dianthus Therapeutics Inc | 252828108 | Feb 2026 | 38,214 | $2.1M | 1.53% | EC |
| 24 | Mineralys Therapeutics Inc | 603170101 | Feb 2026 | 70,537 | $2.1M | 1.50% | EC |
| 25 | Galapagos Nv | 36315X101 | Feb 2026 | 58,387 | $2.0M | 1.42% | EC |
| 26 | Maze Therapeutics Inc | 578784100 | Feb 2026 | 42,889 | $2.0M | 1.42% | EC |
| 27 | Zai Lab Ltd | 98887Q104 | Feb 2026 | 99,972 | $1.9M | 1.39% | EC |
| 28 | Stoke Therapeutics Inc | 86150R107 | Feb 2026 | 50,908 | $1.9M | 1.34% | EC |
| 29 | Nuvation Bio Inc | 67080N101 | Feb 2026 | 305,559 | $1.8M | 1.31% | EC |
| 30 | Celldex Therapeutics Inc | 15117B202 | Feb 2026 | 59,226 | $1.8M | 1.29% | EC |
| 31 | Olema Pharmaceuticals Inc | 68062P106 | Feb 2026 | 70,109 | $1.7M | 1.23% | EC |
| 32 | Pharvaris Nv | N69605108 | Feb 2026 | 57,094 | $1.6M | 1.17% | EC |
| 33 | Vericel Corp | 92346J108 | Feb 2026 | 45,076 | $1.6M | 1.17% | EC |
| 34 | Relay Therapeutics Inc | 75943R102 | Feb 2026 | 154,480 | $1.6M | 1.15% | EC |
| 35 | Tyra Biosciences Inc | 90240B106 | Feb 2026 | 47,570 | $1.6M | 1.15% | EC |
| 36 | Agios Pharmaceuticals Inc | 00847X104 | Feb 2026 | 51,973 | $1.6M | 1.14% | EC |
| 37 | Sarepta Therapeutics Inc | 803607100 | Feb 2026 | 93,395 | $1.6M | 1.13% | EC |
| 38 | Oculis Holding Ag | H5870P102 | Feb 2026 | 50,955 | $1.5M | 1.09% | EC |
| 39 | Amylyx Pharmaceuticals Inc | 03237H101 | Feb 2026 | 97,879 | $1.5M | 1.08% | EC |
| 40 | Oruka Therapeutics Inc | 687604108 | Feb 2026 | 43,144 | $1.5M | 1.08% | EC |
| 41 | Novavax Inc | 670002401 | Feb 2026 | 144,833 | $1.5M | 1.06% | EC |
| 42 | Immunocore Holdings Plc | 45258D105 | Feb 2026 | 45,035 | $1.5M | 1.05% | EC |
| 43 | Sionna Therapeutics Inc | 829401108 | Feb 2026 | 39,776 | $1.5M | 1.05% | EC |
| 44 | Palvella Therapeutics Inc | 697947109 | Feb 2026 | 10,552 | $1.4M | 1.03% | EC |
| 45 | Mbx Biosciences Inc | 55287L101 | Feb 2026 | 40,022 | $1.3M | 0.94% | EC |
| 46 | Zenas Biopharma Inc | 98937L105 | Feb 2026 | 47,842 | $1.3M | 0.91% | EC |
| 47 | Immatics Nv | N44445109 | Feb 2026 | 119,488 | $1.2M | 0.90% | EC |
| 48 | Rapport Therapeutics Inc | 75383L102 | Feb 2026 | 42,477 | $1.2M | 0.89% | EC |
| 49 | Corvus Pharmaceuticals Inc | 221015100 | Feb 2026 | 66,564 | $1.2M | 0.88% | EC |
| 50 | Taysha Gene Therapies Inc | 877619106 | Feb 2026 | 244,138 | $1.1M | 0.80% | EC |
| 51 | Moonlake Immunotherapeutics | 61559X104 | Feb 2026 | 63,143 | $1.1M | 0.80% | EC |
| 52 | Day One Biopharmaceuticals Inc | 23954D109 | Feb 2026 | 91,514 | $970K | 0.70% | EC |
| 53 | Geron Corp | 374163103 | Feb 2026 | 568,951 | $956K | 0.69% | EC |
| 54 | Mannkind Corp | 56400P706 | Feb 2026 | 273,687 | $898K | 0.65% | EC |
| 55 | Compass Therapeutics Inc | 20454B104 | Feb 2026 | 158,523 | $896K | 0.65% | EC |
| 56 | Arrivent Biopharma Inc | 04272N102 | Feb 2026 | 36,792 | $845K | 0.61% | EC |
| 57 | Theravance Biopharma Inc | G8807B106 | Feb 2026 | 45,164 | $824K | 0.60% | EC |
| 58 | Bicara Therapeutics Inc | 055477103 | Feb 2026 | 48,826 | $819K | 0.59% | EC |
| 59 | Ars Pharmaceuticals Inc | 82835W108 | Feb 2026 | 88,100 | $818K | 0.59% | EC |
| 60 | Xencor Inc | 98401F105 | Feb 2026 | 63,648 | $813K | 0.59% | EC |
| 61 | Kalvista Pharmaceuticals Inc | 483497103 | Feb 2026 | 45,051 | $733K | 0.53% | EC |
| 62 | Kura Oncology Inc | 50127T109 | Feb 2026 | 77,558 | $677K | 0.49% | EC |
| 63 | Rigel Pharmaceuticals Inc | 766559702 | Feb 2026 | 16,180 | $562K | 0.41% | EC |
| 64 | Alto Neuroscience Inc | 02157Q109 | Feb 2026 | 27,688 | $545K | 0.39% | EC |
| 65 | Design Therapeutics Inc | 25056L103 | Feb 2026 | 50,771 | $530K | 0.38% | EC |
| 66 | Vanda Pharmaceuticals Inc | 921659108 | Feb 2026 | 52,672 | $469K | 0.34% | EC |
| 67 | Fulgent Genetics Inc | 359664109 | Feb 2026 | 27,554 | $422K | 0.31% | EC |
| 68 | Regenxbio Inc | 75901B107 | Feb 2026 | 45,118 | $408K | 0.30% | EC |
| 69 | Altimmune Inc | 02155H200 | Feb 2026 | 92,999 | $401K | 0.29% | EC |
| 70 | Tectonic Therapeutic Inc | 878972108 | Feb 2026 | 16,682 | $391K | 0.28% | EC |
| 71 | Zura Bio Ltd | G9TY5A101 | Feb 2026 | 57,952 | $384K | 0.28% | EC |
| 72 | Upstream Bio Inc | 91678A107 | Feb 2026 | 48,162 | $370K | 0.27% | EC |
| 73 | Anavex Life Sciences Corp | 032797300 | Feb 2026 | 79,635 | $353K | 0.26% | EC |
| 74 | Forte Biosciences Inc | 34962G208 | Feb 2026 | 11,166 | $337K | 0.24% | EC |
| 75 | Atea Pharmaceuticals Inc | 04683R106 | Feb 2026 | 69,634 | $326K | 0.24% | EC |
| 76 | Neurogene Inc | 64135M105 | Feb 2026 | 13,806 | $324K | 0.23% | EC |
| 77 | Akebia Therapeutics Inc | 00972D105 | Feb 2026 | 236,514 | $310K | 0.22% | EC |
| 78 | Protara Therapeutics Inc | 74365U107 | Feb 2026 | 46,015 | $293K | 0.21% | EC |
| 79 | Delcath Systems Inc | 24661P807 | Feb 2026 | 31,472 | $280K | 0.20% | EC |
| 80 | Aclaris Therapeutics Inc | 00461U105 | Feb 2026 | 96,567 | $277K | 0.20% | EC |
| 81 | Rezolute Inc | 76200L309 | Feb 2026 | 82,647 | $265K | 0.19% | EC |
| 82 | Candel Therapeutics Inc | 137404109 | Feb 2026 | 48,929 | $257K | 0.19% | EC |
| 83 | Bicycle Therapeutics Plc | 088786108 | Feb 2026 | 44,503 | $255K | 0.18% | EC |
| 84 | Aardvark Therapeutics Inc | 002942100 | Feb 2026 | 19,407 | $242K | 0.18% | EC |
| 85 | Arcturus Therapeutics Holdings Inc | 03969T109 | Feb 2026 | 25,324 | $208K | 0.15% | EC |
| 86 | State Street Institutional Treasury Plus Money Market Fund | 857492862 | Feb 2026 | 50,717 | $51K | 0.04% | STIV |
| 87 | Novo Nordisk A/s | 2600057D | Feb 2026 | 1,233 | $0 | 0.00% | DE |
| 88 | Astrazeneca Plc | 2334482D | Feb 2026 | 36,586 | $0 | 0.00% | DE |
| 89 | Chinook Therapeutics Inc | 1835589D | Feb 2026 | 20,700 | $0 | 0.00% | DE |
| 90 | N/A | SECLEND | Feb 2026 | 0 | $0 | 0.00% | STIV |
| 91 | Omniab Inc | 68218J301 | Feb 2026 | 3,653 | $0 | 0.00% | DE |
| 92 | Omniab Inc | 68218J202 | Feb 2026 | 3,653 | $0 | 0.00% | DE |